Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pulse Biosciences, Inc (PLSE) had Return on Equity of -24.78% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.43M |
|
$-24.66M |
|
$0.27M |
|
$0.16M |
|
$25.71M |
|
$-25.27M |
|
$0.61M |
|
$-24.66M |
|
$-24.66M |
|
$-24.66M |
|
$-24.66M |
|
$-24.66M |
|
$-24.66M |
|
$-25.27M |
|
$-25.02M |
|
69.20M |
|
69.20M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$105.70M |
|
$1.06M |
|
$9.86M |
|
$115.56M |
|
$10.98M |
|
-- |
|
$5.09M |
|
$16.06M |
|
$99.50M |
|
$96.49M |
|
$99.50M |
|
70.80M |
|
| Cash Flow Statement Financials | |
$-33.30M |
|
$-0.12M |
|
$54.31M |
|
$80.73M |
|
$101.62M |
|
$20.89M |
|
$6.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
37.10% |
|
-5823.04% |
|
-5823.04% |
|
-- |
|
-5681.34% |
|
-5681.34% |
|
$-33.43M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.16 |
|
3.56 |
|
25.30 |
|
|
Return on Equity |
-24.78% |
-25.55% |
|
-21.34% |
|
-24.78% |
|
$1.41 |
|
$-0.48 |
|
$-0.48 |
|